Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease- Based On Korean National Insurnance Claims Data

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.1411
https://www.valueinhealthjournal.com/article/S1098-3015(17)31745-X/fulltext
Section Title : Disease-Specific Studies
Section Order : 1269
First Page : A632
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31745-X&doi=10.1016/j.jval.2017.08.1411
HEOR Topics :
Tags :
Regions :